Neural Regeneration Research

Article	Citations
Neuromodulation techniques for modulating cognitive function: enhancing stimulation precision and intervention effects	270
Role of mitophagy in spinal cord ischemia-reperfusion injury	240
Role of the medullary reticular formation in motor control and functional recovery following spinal cord injury	154
Intersection of mitochondrial dysfunction and myelination: an overlooked aspect in neurodevelopmental disorders	102
Chromatin accessibility regulates axon regeneration	96
Could inorganic polyphosphate be a valid target against neuronal senescence?	92
Chlorogenic acid alleviates hypoxic-ischemic brain injury in neonatal mice	79
The role of exosomes in adult neurogenesis: implications for neurodegenerative diseases	77
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial	68
Bioinformatics analysis of ferroptosis in spinal cord injury	62
Working toward an integrated plasticity/network framework for repetitive transcranial magnetic stimulation to inform tailored treatments	59
Respiratory plasticity following spinal cord injury: perspectives from mouse to man	56
Correlation between cerebral cortex changes and clinical features in patients with neuromyelitis optica spectrum disorder with normal-appearing brain tissue: a case-control study	53
Experimental nerve transfer model in the neonatal rat	48
The gut microbiome: implications for neurogenesis and neurological diseases	48
Use of a tissue clearing technique combined with retrograde trans-synaptic viral tracing to evaluate changes in mouse retinorecipient brain regions following optic nerve crush	48
Spliceosomal GTPase Eftud2 regulates microglial activation and polarization	47
Retraction: Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury	46
Retraction: Spinal genesis of Mayer waves	45
Retraction: Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy	44
Role of astrocytes and microglia in hepatic encephalopathy associated with advanced chronic liver disease: lessons from animal studies	43
Dynamic development of microglia and macrophages after spinal cord injury	43
Nerve root magnetic stimulation regulates the synaptic plasticity of injured spinal cord by ascending sensory pathway	43
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: targeting brain metabolic and vascular restoration	42
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	42

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease	41
Chemical exchange saturation transfer MRI for neurodegenerative diseases: an update on clinical and preclinical studies	41
Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets	40
Melatonin and mitochondrial stress: new insights into age-related neurodegeneration	40
TDP-43 is a key molecule accelerating development of Alzheimer’s disease following traumatic brain injury	39
Liquid biopsies in psychiatric disorders: identifying peripheral biomarkers of brain health	39
Alpha2-adrenergic receptor activation reinstates motor deficits in rats recovering from cortical injury	39
Biomarkers for synaptic dysfunction in Alzheimer’s disease	39
Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity	38
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	38
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	38
Strategies for translating proteomics discoveries into drug discovery for dementia	37
The dorsal root ganglion as a target for neurorestoration in neuropathic pain	37
Association of DNA methylation/demethylation with the functional outcome of stroke in a hyperinflammatory state	37
Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?	36
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	36
Cyclophilin D-induced mitochondrial impairment confers axonal injury after intracerebral hemorrhage in mice	35
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	34
CircLphn3 protects the blood-brain barrier in traumatic brain injury	34
Vagus nerve stimulation is a potential treatment for ischemic stroke	34
The dopaminergic system and Alzheimer’s disease	33
Modulation of the Nogo signaling pathway to overcome amyloid-β-mediated neurite inhibition in human pluripotent stem cell–derived neurites	33
Apolipoprotein E elicits target-directed miRNA degradation to maintain neuronal integrity	33
Harnessing therapeutic potential of induced pluripotent stem cell–derived endothelial cells for remyelination in the central nervous system	33
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	32
Extracellular vesicles drive tau spreading in Alzheimer’s disease	32
Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials	32
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	32
Neuroprotective potential for mitigating ischemia-reperfusion-induced damage	31
Vimentin as a potential target for diverse nervous system diseases	31
Quantitative proteomic and phosphoproteomic analyses of the hippocampus reveal the involvement of NMDAR1 signaling in repetitive mild traumatic brain injury	31
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets	31
Riding the rails – different modes for RNA complex transport in axons	31
Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	31
Quo vadis? Bioengineered polysaccharide-based hydrogel scaffolds for damaged central nervous system recovery and regeneration	30
Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease	30
Response to Letter to the Editor	30
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	30
Protocadherin gamma C3: a new player in regulating vascular barrier function	29
In vivo direct neuronal conversion as a therapeutic strategy for ischemic stroke	29
Photobiomodulation inhibits the expression of chondroitin sulfate proteoglycans after spinal cord injury via the Sox9 pathway	29
Reevaluating the cause of laminopathy in Alzheimer’s disease	29
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	29
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	29
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	29
Differential response of injured and healthy retinas to syngeneic and allogeneic transplantation of a clonal cell line of immortalized olfactory ensheathing glia: a double-edged sword	29
Purinergic signaling systems across comparative models of spinal cord injury	28
Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis	28
Choroid plexus imaging to track neuroinflammation – a translational model for mouse and human studies	28
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	28

Exercise preconditioning alleviates ischemia-induced memory deficits by increasing circulating adiponectin	28
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	28
Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice	27
Angiotensin-(1–7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson’s disease	27
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	27
On implications of somatostatin in diabetic retinopathy	27
Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration	26
Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers	26
Glycolytic dysregulation in Alzheimer’s disease: unveiling new avenues for understanding pathogenesis and improving therapy	26
Transcription factors promote neural regeneration after spinal cord injury	26
Oligodendroctyes: the forgotten players of diabetes pathophysiology	26
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	25
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	25
Corrigendum: Genistein suppresses mitochondrial apoptotic pathway in rat hippocampal neurons with Alzheimer's disease	25
Defined hydrogels for spinal cord organoids: challenges and potential applications	25
Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection?	24
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease	24
Limitations in activities of daily living increase the risk of stroke in older Chinese adults: a population-based longitudinal study	24
Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury	24
NECAB family of neuronal calcium-binding proteins in health and disease	24
Decline and fall of aging astrocytes: the human perspective	24
Complementary roles of glial cells in generating region-specific neuroinflammatory responses and phagocytosis in Parkinson’s disease	23
Microglia and astrocytes mediate synapse engulfment in a MER tyrosine kinase-dependent manner after traumatic brain injury	23
Neuropeptide cholecystokinin: a key neuromodulator for hippocampal functions	23
Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations	23
The gut–eye axis: from brain neurodegenerative diseases to age-related macular degeneration	23
Non-cell autonomous role of astrocytes in axonal degeneration of cortical projection neurons in hereditary spastic paraplegias	23
Neuroinflammation and glial activation in the central nervous system: a metabolic perspective	23
Genetic pathways in cerebral palsy: a review of the implications for precision diagnosis and understanding disease mechanisms	23
Exploring the role of N-acetyltransferases in diseases: a focus on N-acetyltransferase 9 in neurodegeneration	23
Heterogeneous patterning of blood-brain barrier and adaptive myelination as renewing key in gray and white matter	23
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	23
Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study	23
Reduced non-CpG methylation is a potential epigenetic target after spinal cord injury	23
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	22
The mechanism by which hyperbaric oxygen treatment alleviates spinal cord injury: genome-wide transcriptome analysis	22
Axon degeneration: new actor in an old play	22
Advances in spinal cord injury: insights from non-human primates	22
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration	22
Unilateral rNurr1-V5 transgene expression in nigral dopaminergic neurons mitigates bilateral neuropathology and behavioral deficits in parkinsonian rats with α-synucleinopathy	22
Ambroxol, the cough expectorant with neuroprotective effects	22
Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration	22
Silk-based nerve guidance conduits with macroscopic holes modulate the vascularization of regenerating rat sciatic nerve	21
Use of induced pluripotent stem cell-derived brain cells, organoids, assembloids, and blood-brain barrier models in understanding alcohol and anesthetic-induced brain injuries: an emerging perspective	21
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	21
Traumatic brain injury treatment using a rodent model of homelessness	21
Mechanism by which Rab5 promotes regeneration and functional recovery of zebrafish Mauthner axons	21
Amyloid-β-induced disruption of axon-initial-segment mitochondria localization: consequences for TAU missorting in Alzheimer’s disease pathology	21
Role of pituitary adenylate cyclase-activating polypeptide in peripheral nerve regeneration: a cellular and molecular perspective	21
A dysregulated calcium homeostasis as the earliest pathological sign in stem cell-derived Parkinson's disease neurons?	21
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	21
Optic nerve injury-induced regeneration in the adult zebrafish is accompanied by spatiotemporal changes in mitochondrial dynamics	21
A sphingolipid message promotes neuronal health across generations	21
Focusing on the tetra-partite synapse in Parkinson’s disease research using human patient-derived neurons	21
Role of exercise in the brain: focus on oligodendrocytes and remyelination	21
Repetitive transcranial magnetic stimulation promotes neurological functional recovery in rats with traumatic brain injury by upregulating synaptic plasticity-related proteins	21
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	20
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	20
Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect	20
Axon regeneration: membrane expansion and lipidomics	20
Using microglia-derived extracellular vesicles to capture diversity of microglial activation phenotypes following neurological injury	20
The role of miRNA in retinal ganglion cell health and disease	20
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	20
Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?	20
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	20
Modifying the progression of Parkinson's disease through movement interventions: multimodal quantification of underlying mechanisms	20
Primary lateral sclerosis: more than just an upper motor neuron disease	20
The role of crm-1 in ionizing radiation-induced nervous system dysfunction in Caenorhabditis elegans	20
Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	20
Approaches to quantify axonal morphology for the analysis of axonal degeneration	20
Myeloperoxidase: a new target for the treatment of stroke?	20
Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury	20
Research advances on how metformin improves memory impairment in “chemobrain”	19
Ultra-early amplitude decrement after repetitive nerve stimulation supports early neuromuscular junction injury in amyotrophic lateral sclerosis: a prospective cross-sectional study	19
Effect of caffeine in the intraventricular hemorrhage of the preterm newborn	19
Use of donepezil for neurocognitive recovery after brain injury in adult and pediatric populations: a scoping review	19
Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease	19
Tandem Mass Tag-based proteomics analysis reveals the vital role of inflammation in traumatic brain injury in a mouse model	19
A simple human cell model for TAU trafficking and tauopathy-related TAU pathology	19
Clustering of voltage-gated ion channels as an evolutionary trigger of myelin formation	19

cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?	19
Growth associated protein 43 and neurofilament immunolabeling in the transected lumbar spinal cord of lizard indicates limited axonal regeneration	19
Plasticity of callosal neurons in the contralesional cortex following traumatic brain injury	18
Cell-type resolved transcriptomic approaches for dissecting selective vulnerability in neurodegeneration	18
ATAT1 deficiency enhances microglia/macrophage-mediated erythrophagocytosis and hematoma absorption following intracerebral hemorrhage	18
Substrate topography as a powerful tool to modify glial cell biology and interactions	18
A cup of coffee for a brain long life	18
From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic pain	18
Mice lacking perforin have improved regeneration of the injured femoral nerve	18
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	18
Etiology matters: genetic and acquired prion diseases engage different mechanisms at a presymptomatic stage	18
A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G	18
Pathology-induced NG2 proteoglycan expression in microglia	18
On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics	18
Patient-specific monocyte-derived microglia as a screening tool for neurodegenerative diseases	18
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	18
Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update	18
Telomerase and neurons: an unusual relationship	18
Inhibiting phosphatase and actin regulator 1 expression is neuroprotective in the context of traumatic brain injury	18
Technological advances expand our knowledge of lysosomal dysfunction in neurodegeneration	17
From the dust: extracellular vesicles as regulators of development and neuroregeneration	17
Utilizing multiphoton imaging and integrative clearing to reveal sex differences in neuroimmune interactions after nerve injury	17
Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option	17
Is it possible to develop a cerebellar reserve?	17
Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease	17
Effects of electroacupuncture on pain sensation in a rat model of hyperalgesia with nicotine dependence	17
FK506 contributes to peripheral nerve regeneration by inhibiting neuroinflammatory responses and promoting neuron survival	17
Visual system repair: what’s next?	17
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	17
Dual-directional regulation of spinal cord injury and the gut microbiota	17
Piezo1 suppression reduces demyelination after intracerebral hemorrhage	17
NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality	17
Identification of key genes involved in recovery from spinal cord injury in adult zebrafish	17
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	17
Synapses and dendritic spines are eliminated in the primary visual cortex of mice subjected to chronic intraocular pressure elevation	17
Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging	17
Dynamic transcriptional programs define distinct mammalian cortical lineages	17
Unfolded p53 in non-neuronal cells supports bacterial etiology of Alzheimer’s disease	17
Long non-coding RNA MEG3 regulates autophagy after cerebral ischemia/reperfusion injury	17
Hemorrhagic transformation in patients with large-artery atherosclerotic stroke is associated with the gut microbiota and lipopolysaccharide	17
Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement	17
In vitro microglia models: the era of engineered cell microenvironments	17
Tilting homeostatic and dyshomeostatic microglial balance in health and disease: transforming growth factor-beta1 as a critical protagonist	16
SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiology	16
Implications of Olig2 silencing in oligodendrocyte precursor cells	16
Calcium-sensitive protein MLC1 as a possible modulator of the astrocyte functional state	16
Transplantation of human placental chorionic plate-derived mesenchymal stem cells for repair of neurological damage in neonatal hypoxic-ischemic encephalopathy	16
Circadian rhythm disruption and retinal dysfunction: a bidirectional link in Alzheimer's disease?	16
Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues	16
Amyloid-beta pathology–induced nanoscale synaptic disruption: the case of the GABAB–GIRK assembly	16
Emerging role of A-kinase anchoring protein 5 signaling in reward circuit function	16
Activation of metabotropic glutamate receptor 1 regulates hippocampal CA1 region excitability in rats with status epilepticus by suppressing the HCN1 channel	16
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	16
Traumatic brain injury induced by exposure to blast overpressure via ear canal	16
PGLYRP1 protein as a novel mediator of cellular dialogue in neuroinflammation	16
Iron, the endolysosomal system and neuroinflammation: a matter of balance	16
Combinatorial therapies for spinal cord injury repair	16
Colony stimulating factor 1: friend or foe of neurons?	16
Functions of nuclear factor Y in nervous system development, function and health	16
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	16
The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier	16
Boosting corticospinal system synaptic plasticity to recover motor functions	16
Resilience to structural and molecular changes in excitatory synapses in the hippocampus contributes to cognitive function recovery in Tg2576 mice	16
Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations	16
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	16
Axonal protein synthesis in central nervous system regeneration: is building an axon a local matter?	16
The physiological role of the unfolded protein response in the nervous system	16
Perilipin-2 mediates ferroptosis in oligodendrocyte progenitor cells and myelin injury after ischemic stroke	15
Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	15
New insights into the effects of APP gene dose on synapse in Down syndrome	15
Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injury	15
Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseases	15
Decoding complexity: the need to enhance precision and streamline spatial understanding in neuroscience	15
A spotlight on dosage and subject selection for effective neuroprotection: exploring the central role of mitochondria	15
Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?	15
Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice	15
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	15
Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease	15
Assessment of hindlimb motor recovery after severe thoracic spinal cord injury in rats: classification of CatWalk XT® gait analysis parameters	15
Design and redesign journey of a drug for transthyretin amyloidosis	15
The emerging role of mesenchymal stem cell–derived extracellular vesicles to ameliorate hippocampal NLRP3 inflammation induced by binge-like ethanol treatment in adolescence	15
The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury	15
Transforming growth factor-beta 1 enhances discharge activity of cortical neurons	15
A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury	15
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	15
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	15
Neat1 decreases neuronal apoptosis after oxygen and glucose deprivation	15
Small heat shock protein B8: from cell functions to its involvement in diseases and potential therapeutic applications	15
Stepping up after spinal cord injury: negotiating an obstacle during walking	15
Thrombin increases the expression of cholesterol 25-hydroxylase in rat astrocytes after spinal cord injury	15
Neuroinflammation as a therapeutic target in Huntington’s disease	15
Role of peripheral amyloid-β aggregates in Alzheimer’s disease: mechanistic, diagnostic, and therapeutic implications	15
Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets	15
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	15
High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke	14